Methods of Evaluating the Utility of Continuous Glucose Monitor Alerts

Background: The evaluation of continuous glucose monitor (CGM) alert performance should reflect patient use in real time. By evaluating alerts as real-time events, their ability to both detect and predict low and high blood glucose (BG) events can be examined. Method: True alerts (TA) were defined as a CGM alert occurring within ± 30 minutes from the beginning of a low or a high BG event. The TA time to detection was calculated as [time of CGM alert] - [beginning of event]. False alerts (FA) were defined as a BG event outside of the alert zone within ± 30 minutes from a CGM alert. Analysis was performed comparing DexCom™ SEVEN® PLUS CGM data to BG measured with a laboratory analyzer. Results: Of 49 low glucose events (BG <70 mg/dl), with the CGM alert set to 90 mg/dl, the TA rate was 91.8%. For 50% of TAs, the CGM alert preceded the event by at least 21 minutes. The FA rate was 25.0%. Similar results were found for high alerts. Conclusion: Continuous glucose monitor alerts are capable of both detecting and predicting low and high BG events. The setting of alerts entails a trade-off between predictive ability and FA rate. Realistic analysis of this trade-off will guide patients in the effective utilization of CGM.

[1]  F. Cameron,et al.  Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. , 2009, Diabetes technology & therapeutics.

[2]  R. Bergenstal,et al.  Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System. , 2009, Diabetes technology & therapeutics.

[3]  Howard Wolpert,et al.  Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2009 .

[4]  F. Ovalle,et al.  Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes , 2009 .

[5]  L. Jovanovic,et al.  Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values , 2006, Diabetes Care.

[6]  R O Potts,et al.  Detection of hypoglycemia with the GlucoWatch biographer. , 2001, Diabetes care.

[7]  Howard Zisser,et al.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. , 2006, Diabetes care.

[8]  Howard C. Zisser,et al.  Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. , 2007, Diabetes technology & therapeutics.

[9]  R. Beck,et al.  GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. , 2004, Diabetes technology & therapeutics.

[10]  R O Potts,et al.  Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. , 2001, Biosensors & bioelectronics.

[11]  S. Garg,et al.  Use of continuous glucose monitoring to improve diabetes mellitus management. , 2007, Endocrinology and metabolism clinics of North America.

[12]  S. Garg,et al.  Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. , 2004, Diabetes care.

[13]  J. Brauker,et al.  Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor. , 2009, Diabetes technology & therapeutics.

[14]  J. Brauker,et al.  Continuous glucose sensing: future technology developments. , 2009, Diabetes technology & therapeutics.

[15]  S. Garg,et al.  Continuous Home Monitoring of Glucose , 2007, Diabetes Care.

[16]  J. Mastrototaro,et al.  Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. , 2004, Diabetes technology & therapeutics.